A BILL TO BE ENTITLED
AN ACT to clarify that the practice of horseshoeing is not the practice of veterinary medicine and to Study Veterinary pharmaceutical compounding.
The General Assembly of North Carolina enacts:
SECTION 1.  G.S. 90‑187.10 is amended by adding a new subdivision to read:
"§ 90‑187.10.  Necessity for license; certain practices exempted.
No person shall engage in the practice of veterinary medicine or own all or part interest in a veterinary medical practice in this State or attempt to do so without having first applied for and obtained a license for such purpose from the North Carolina Veterinary Medical Board, or without having first obtained from the Board a certificate of renewal of license for the calendar year in which the person proposes to practice and until the person shall have been first licensed and registered for such practice in the manner provided in this Article and the rules and regulations of the Board.
Nothing in this Article shall be construed to prohibit:
...
(11)	Any farrier or person actively engaged in the activity or profession of shoeing hooved animals as long as his or her actions are limited to the art of shoeing hooved animals or trimming, clipping, or maintaining hooves."
SECTION 2.  The Veterinary Division of the Department of Agriculture and Consumer Services shall study the practice of veterinary pharmaceutical compounding (VPC). The study shall include the following:
(1)	A review of current State and federal policies regulating VPC, taking into account the ongoing dialogue between the U.S. Food and Drug Administration and the American Veterinary Medical Association regarding the legality of compounding animal drugs from bulk drug substances.
(2)	Recommendations for additional legislation needed to increase protection of animals administered compounded pharmaceutical agents and provide necessary oversight of (i) veterinary compounding pharmacies, (ii) veterinary pharmaceutical manufacturers engaging in VPC, and (iii) veterinary practices that prescribe or administer compounded pharmaceutical agents. 
In conducting its study, the Division shall consult with the North Carolina Board of Pharmacy and the North Carolina Veterinary Medical Board. The Division shall submit its report and any recommendations to the Joint Legislative Administrative Procedure Oversight Committee, the Joint Legislative Oversight Committee on Agriculture and Natural and Economic Resources, and the Environmental Review Commission no later than March 1, 2018.
SECTION 3.  This act is effective when it becomes law.